Heartflow (NASDAQ:HTFL) Trading 6.5% Higher – Still a Buy?

Heartflow, Inc. (NASDAQ:HTFL)’s stock price traded up 6.5% during trading on Tuesday . The stock traded as high as $44.32 and last traded at $44.6610. Approximately 1,241,238 shares changed hands during mid-day trading, a decline of 17% from the average daily volume of 1,490,980 shares. The stock had previously closed at $41.94.

Analyst Ratings Changes

A number of research analysts have weighed in on HTFL shares. Freedom Capital raised shares of Heartflow to a “strong-buy” rating in a research note on Tuesday, June 30th. Weiss Ratings raised Heartflow from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, August 7th. Benchmark restated a “buy” rating on shares of Heartflow in a research note on Friday, August 14th. Stifel Nicolaus upped their price target on shares of Heartflow from $40.00 to $45.00 and gave the company a “buy” rating in a research note on Friday, August 14th. Finally, Wells Fargo & Company lifted their price objective on Heartflow from $37.00 to $39.00 and gave the company an “overweight” rating in a report on Friday, August 14th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $43.43.

Heartflow Stock Up 0.7%

The company has a 50 day simple moving average of $30.00 and a 200 day simple moving average of $28.05. The stock has a market cap of $3.96 billion and a price-to-earnings ratio of -24.88.

Heartflow (NASDAQ:HTFL) last announced its quarterly earnings results on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.15. The company had revenue of $64.08 million during the quarter. Heartflow had a negative net margin of 55.82% and a negative return on equity of 23.52%. The company’s revenue was up 47.7% compared to the same quarter last year. As a group, analysts predict that Heartflow, Inc. will post -0.82 earnings per share for the current fiscal year.

Insider Activity at Heartflow

In related news, CEO John C.M. Farquhar sold 38,900 shares of the company’s stock in a transaction that occurred on Wednesday, June 24th. The stock was sold at an average price of $35.00, for a total value of $1,361,500.00. Following the sale, the chief executive officer directly owned 457,935 shares in the company, valued at $16,027,725. This represents a 7.83% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Campbell Rogers sold 9,219 shares of the stock in a transaction on Monday, August 17th. The stock was sold at an average price of $41.23, for a total transaction of $380,099.37. Following the sale, the insider owned 86,459 shares of the company’s stock, valued at approximately $3,564,704.57. This trade represents a 9.64% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders sold 131,365 shares of company stock valued at $4,257,216. Corporate insiders own 7.70% of the company’s stock.

Institutional Investors Weigh In On Heartflow

Hedge funds have recently added to or reduced their stakes in the business. TrueMark Investments LLC increased its stake in shares of Heartflow by 1.4% in the 1st quarter. TrueMark Investments LLC now owns 26,885 shares of the company’s stock valued at $654,000 after acquiring an additional 379 shares in the last quarter. Caitong International Asset Management Co. Ltd acquired a new position in shares of Heartflow during the fourth quarter worth approximately $27,000. Strs Ohio increased its stake in Heartflow by 35.3% during the 1st quarter. Strs Ohio now owns 4,600 shares of the company’s stock valued at $112,000 after purchasing an additional 1,200 shares in the last quarter. Russell Investments Group Ltd. acquired a new position in Heartflow during the fourth quarter worth $45,000. Finally, Legal & General Group Plc bought a new position in shares of Heartflow in the third quarter valued at $59,000.

Heartflow Company Profile

HeartFlow, Inc (NASDAQ: HTFL) is a medical technology company that develops non-invasive diagnostic solutions for coronary artery disease. The company’s core offering translates coronary CT angiography (CTA) data into a patient-specific, three-dimensional physiological model of the coronary arteries. Using advanced image processing and computational modeling, HeartFlow’s analysis estimates fractional flow reserve (FFR) values throughout the coronary tree to identify ischemia-producing lesions without the need for invasive pressure-wire measurements.

HeartFlow’s cloud-based service integrates with clinical workflows: clinicians submit coronary CTA images and receive a detailed, color-coded 3D map and report that highlights lesion-specific FFR values and physiological impact.